Cargando…
Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)
BACKGROUND: To determine prostate displacement during extreme hypofractionated volume modulated arc radiotherapy (VMAT) using pre- and post-treatment orthogonal images with three implanted gold seed fiducial markers. METHODS: A total of 150 image pairs were obtained from 30 patients who underwent ex...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251941/ https://www.ncbi.nlm.nih.gov/pubmed/25430973 http://dx.doi.org/10.1186/s13014-014-0262-y |
_version_ | 1782347120731226112 |
---|---|
author | Gladwish, Adam Pang, Geordi Cheung, Patrick D’Alimonte, Laura Deabreu, Andrea Loblaw, Andrew |
author_facet | Gladwish, Adam Pang, Geordi Cheung, Patrick D’Alimonte, Laura Deabreu, Andrea Loblaw, Andrew |
author_sort | Gladwish, Adam |
collection | PubMed |
description | BACKGROUND: To determine prostate displacement during extreme hypofractionated volume modulated arc radiotherapy (VMAT) using pre- and post-treatment orthogonal images with three implanted gold seed fiducial markers. METHODS: A total of 150 image pairs were obtained from 30 patients who underwent extreme hypofractionated radiotherapy to a dose of 40 Gy in five fractions on standard linear accelerators. Position verification was obtained with orthogonal x-rays before and after treatment and were used to determine intra-fraction prostate displacement. RESULTS: The mean prostate displacements were 0.03 ± 1.23 mm (1SD), 0.18 ± 1.55 mm, and 0.37 ± 1.95 mm in the left-right, superior-inferior, and anterior-posterior directions, respectively. The mean 3D displacement was 2.32 ± 1.55 mm. Only 6 (4%) fractions had a 3D displacement of >5 mm. The average time of treatment delivery for a given fraction was 195 ± 59 seconds. CONCLUSIONS: The mean intra-fraction prostate displacement during a course of extreme hypofractionated radiotherapy delivered via VMAT, continues to be small. Clinical margins typically used in a similar fixed-angle IMRT treatment are adequate. The use of VMAT in further extreme hypofractionation may limit prostatic motion uncertainties that would be otherwise be associated with longer treatment times. |
format | Online Article Text |
id | pubmed-4251941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42519412014-12-04 Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT) Gladwish, Adam Pang, Geordi Cheung, Patrick D’Alimonte, Laura Deabreu, Andrea Loblaw, Andrew Radiat Oncol Research BACKGROUND: To determine prostate displacement during extreme hypofractionated volume modulated arc radiotherapy (VMAT) using pre- and post-treatment orthogonal images with three implanted gold seed fiducial markers. METHODS: A total of 150 image pairs were obtained from 30 patients who underwent extreme hypofractionated radiotherapy to a dose of 40 Gy in five fractions on standard linear accelerators. Position verification was obtained with orthogonal x-rays before and after treatment and were used to determine intra-fraction prostate displacement. RESULTS: The mean prostate displacements were 0.03 ± 1.23 mm (1SD), 0.18 ± 1.55 mm, and 0.37 ± 1.95 mm in the left-right, superior-inferior, and anterior-posterior directions, respectively. The mean 3D displacement was 2.32 ± 1.55 mm. Only 6 (4%) fractions had a 3D displacement of >5 mm. The average time of treatment delivery for a given fraction was 195 ± 59 seconds. CONCLUSIONS: The mean intra-fraction prostate displacement during a course of extreme hypofractionated radiotherapy delivered via VMAT, continues to be small. Clinical margins typically used in a similar fixed-angle IMRT treatment are adequate. The use of VMAT in further extreme hypofractionation may limit prostatic motion uncertainties that would be otherwise be associated with longer treatment times. BioMed Central 2014-11-28 /pmc/articles/PMC4251941/ /pubmed/25430973 http://dx.doi.org/10.1186/s13014-014-0262-y Text en © Gladwish et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Gladwish, Adam Pang, Geordi Cheung, Patrick D’Alimonte, Laura Deabreu, Andrea Loblaw, Andrew Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT) |
title | Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT) |
title_full | Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT) |
title_fullStr | Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT) |
title_full_unstemmed | Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT) |
title_short | Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT) |
title_sort | prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (vmat) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251941/ https://www.ncbi.nlm.nih.gov/pubmed/25430973 http://dx.doi.org/10.1186/s13014-014-0262-y |
work_keys_str_mv | AT gladwishadam prostaticdisplacementduringextremehypofractionatedradiotherapyusingvolumetricmodulatedarctherapyvmat AT panggeordi prostaticdisplacementduringextremehypofractionatedradiotherapyusingvolumetricmodulatedarctherapyvmat AT cheungpatrick prostaticdisplacementduringextremehypofractionatedradiotherapyusingvolumetricmodulatedarctherapyvmat AT dalimontelaura prostaticdisplacementduringextremehypofractionatedradiotherapyusingvolumetricmodulatedarctherapyvmat AT deabreuandrea prostaticdisplacementduringextremehypofractionatedradiotherapyusingvolumetricmodulatedarctherapyvmat AT loblawandrew prostaticdisplacementduringextremehypofractionatedradiotherapyusingvolumetricmodulatedarctherapyvmat |